---
meta-og:type: article
---

### [◀返回](./home.md)

# 创造力抑制

**创造力抑制** (Creativity depression) 被定义为一个人在执行涉及产出艺术作品或进行新颖的问题解决的任务时，动力和能力都出现了下降哦。[\[1\]](#cite_note-Flaherty2005-1) 这种效应对于任何类型的艺术家来说都可能特别令人沮丧，因为它会导致暂时的创作瓶颈呢。

虽然有些矛盾的是，富有创造力的受试者比普通人更有可能患有抑郁症的历史，但他们的创造性工作并不是在抑郁期间完成的，而是在两次抑郁之间精力充沛的反弹期完成的哦。[\[1\]](#cite_note-Flaherty2005-1)[\[2\]](#cite_note-2)

创造力抑制经常伴随着其他效应一起出现，比如[抑郁](/药效/抑郁.md "Depression")、[\[3\]](#cite_note-von_HeckerMeiser2005-3) [焦虑](/药效/焦虑.md "Anxiety")和[情绪抑制](/药效/情绪抑制.md "Emotion suppression")，这些都会进一步降低这个人的创造能力。[\[1\]](#cite_note-Flaherty2005-1) 这种现象最常见于服用了[中等](/文档/药物剂量分类.md#common "Dosage") [剂量](/文档/给药剂量.md "Dosage")的[抗精神病药](/文档/抗精神病药.md "Antipsychotics")的时候。[\[1\]](#cite_note-Flaherty2005-1)[\[4\]](#cite_note-MoncrieffCohen2009-4)[\[5\]](#cite_note-SzmulewiczSamam.C3.A92016-5) 不过呢，因为服用SSRI类药物[\[6\]](#cite_note-BollingKohlenberg2004-6) 以及在任何多巴胺能化合物的[戒断](/文档/药物戒断反应.md "Withdrawal") 症状期间，也可能会出现这种情况喵。[\[5\]](#cite_note-SzmulewiczSamam.C3.A92016-5)

## 目录

* [1 精神活性物质](#Psychoactive_substances)
* [2 体验报告](#Experience_reports)
* [3 另见](#See_also)
* [4 外部链接](#External_links)
* [5 参考文献](#References)

<!-- 请勿删除或修改，这是一个标记，待识别并填坑（药效索引） -->

### 体验报告

在我们的[体验报告索引](/文档/体验报告索引.md "Experience index")中，描述了这种效应的轶事报告包括：

* [体验报告: \~150mg MDA(口服) \- 一个身份认同错误的案例](/报告/psychounautwiki/Experience:~150mg_MDA(oral)_-_a_case_of_mistaken_identity "Experience:~150mg MDA(oral) - a case of mistaken identity")


### 另见

* [负责任的用药](/文档/负责任的用药索引页.md "Responsible use")
* [主观效应索引](/药效/home.md "Subjective effects index")
* [创造力增强](/药效/创造力增强.md "Creativity enhancement")


### 外部链接

* [创造力 (维基百科)](https://en.wikipedia.org/wiki/Creativity)


### 参考文献

1. ↑ [1\.0](#cite_ref-Flaherty2005_1-0) [1\.1](#cite_ref-Flaherty2005_1-1) [1\.2](#cite_ref-Flaherty2005_1-2) [1\.3](#cite_ref-Flaherty2005_1-3) Flaherty, Alice W. (2005\). "Frontotemporal and dopaminergic control of idea generation and creative drive". *The Journal of Comparative Neurology*. **493** (1\): 147–153\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1002/cne.20768](//doi.org/10.1002%2Fcne.20768). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0021\-9967](//www.worldcat.org/issn/0021-9967). 
2. [↑](#cite_ref-2) Jamison, K. R. (1989\). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2\), 125\-134\. <https://www.ncbi.nlm.nih.gov/pubmed/2734415/>
3. [↑](#cite_ref-von_HeckerMeiser2005_3-0) von Hecker, Ulrich; Meiser, Thorsten (2005\). "Defocused Attention in Depressed Mood: Evidence From Source Monitoring". *Emotion*. **5** (4\): 456–463\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1037/1528\-3542\.5\.4\.456](//doi.org/10.1037%2F1528-3542.5.4.456). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1931\-1516](//www.worldcat.org/issn/1931-1516). 
4. [↑](#cite_ref-MoncrieffCohen2009_4-0) Moncrieff, J.; Cohen, D.; Mason, J. P. (2009\). "The subjective experience of taking antipsychotic medication: a content analysis of Internet data". *Acta Psychiatrica Scandinavica*. **120** (2\): 102–111\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1111/j.1600\-0447\.2009\.01356\.x](//doi.org/10.1111%2Fj.1600-0447.2009.01356.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0001\-690X](//www.worldcat.org/issn/0001-690X). 
5. ↑ [5\.0](#cite_ref-SzmulewiczSamam.C3.A92016_5-0) [5\.1](#cite_ref-SzmulewiczSamam.C3.A92016_5-1) Szmulewicz, Alejandro; Samamé, Cecilia; Caravotta, Pablo; Martino, Diego J.; Igoa, Ana; Hidalgo\-Mazzei, Diego; Colom, Francesc; Strejilevich, Sergio A. (2016\). "Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications". *International Journal of Bipolar Disorders*. **4** (1\). [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1186/s40345\-016\-0047\-3](//doi.org/10.1186%2Fs40345-016-0047-3). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [2194\-7511](//www.worldcat.org/issn/2194-7511). 
6. [↑](#cite_ref-BollingKohlenberg2004_6-0) Bolling, Madelon Y.; Kohlenberg, Robert J. (2004\). "Reasons for Quitting Serotonin Reuptake Inhibitor Therapy: Paradoxical Psychological Side Effects and Patient Satisfaction". *Psychotherapy and Psychosomatics*. **73** (6\): 380–385\. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10\.1159/000080392](//doi.org/10.1159%2F000080392). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0033\-3190](//www.worldcat.org/issn/0033-3190).